EMERYVILLE, Calif.--(BUSINESS WIRE)--Octant, Inc., a synthetic biology drug discovery company designing small molecule, multi-target drug leads for multifactorial diseases announced that it has raised ...
Data-driven therapeutics company Octant Bio is exploring new frontiers of drug development with $80 million in-pocket and a freshly signed Big Pharma partnership. Octant—a historical instrument used ...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Octant, Inc. (“Octant” or the “Company”), a next-generation, data-driven therapeutics company developing programmable biology and chemistry to build precision ...
“We have been working with Mark for over a year as a Board Member and are thrilled to share that he’s now working with us day-to-day,” said Sri Kosuri, CEO of Octant. “Mark’s unique experience and ...
Octant, a company backed by Andreessen Horowitz just now unveiling itself publicly to the world, is using the tools of synthetic biology to buck the latest trends in drug discovery. As the ...
I’ll be honest: I have a weakness for small, independent hotels that are the passion projects of slightly mad entrepreneurs who don’t care about P&Ls or pleasing their investors, nor following ...
Add Yahoo as a preferred source to see more of our stories on Google. Photo: Andrew Brookes/Getty Images Octant, a company backed by Andreessen Horowitz just now unveiling itself publicly to the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results